Sarah Gheuens
CIK 1881190 · Chief Medical Officer · last filed 2026-07-02
Sarah Gheuens is a Chief Medical Officer who has filed 44 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for AGIO, was dated Jul 2, 2026. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.05M
2
44
-$1.93M
Holdings By Company
Recent Filings
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-02 | AGIO | Mixed | +4,368 | -$150.5K | EDGAR |
| 2026-07-02 | VRDN | Grant (A) | — | $0 | EDGAR |
| 2026-07-01 | AGIO | Notice (144) | −4,007 | -$150.5K | EDGAR |
| 2026-06-23 | AGIO | Mixed | — | $0 | EDGAR |
| 2026-04-06 | AGIO | Mixed | +5,560 | -$102.0K | EDGAR |
| 2026-04-02 | AGIO | Notice (144) | −2,940 | -$100.5K | EDGAR |
| 2026-03-03 | AGIO | Mixed | +9,611 | -$117.4K | EDGAR |
| 2026-03-02 | AGIO | Notice (144) | −4,055 | -$122.6K | EDGAR |
| 2026-01-02 | AGIO | Mixed | +3,068 | -$79.4K | EDGAR |
| 2025-12-30 | AGIO | Notice (144) | −2,932 | -$79.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.